← Evidence map

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2024

Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC.

Igor Odintsov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38154514